SHSCX Rating, Research - Blackrock Health Sciences Ops Inv C

Blackrock Health Sciences Ops Inv C (shscx)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help
placeholder_summary.png

Asset Allocation (% of Port)

US Stocks
Non-US Stocks
Bonds
Cash
Other
%
%
%
%
%

Geographic Allocation (% of Port)

North America
Europe
Asia
South America
Africa
Australia + Pacific Islands
Long Term Rating Stock Ratings Help

HOLD

SWOT Statistics

Strengths + Opportunities = 80

Threats + Weaknesses = 60

When strengths & opportunities substantially exceed threats & weaknesses an investment in the shscx mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Blackrock Health Sciences Ops Inv C (SHSCX) Description: SHSCX is a mutual fund, which is an investment that owns a basket of assets. The SHSCX mutual fund was provided by Blackrock and this investment vehicle derives the majority of its value from equity holdings (stocks). Blackrocks mutual fund has a medium management tenure and is in the average fund size classification. SHSCXs minimum initial investment amount is $1000 while the IRA minimum is $100. SHSCXs expense ratio is roughly 2%. The latest SHSCXs front end load was 0% and the back end load was 1%. The Blackrock Health Sciences Ops Inv C (SHSCX) mutual fund falls under the health category. SHSCX focuses its investments in USA and SHSCX is focused on the health industry or fund sector. The Blackrock Health Sciences Ops Inv C (SHSCX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find SHSCXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of SHSCXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks to provide long-term growth of capital. The fund typically invests at least 80% of assets in securities of companies in health science and related industries. Such securities may include common and preferred stock, convertible securities, warrants, depositary receipts and certain derivative securities. It invests more than 25% of assets in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund also may invest up to 20% of total assets in other securities. It may invest without limit in shares of companies through initial public offerings (IPOs). The funds non-diversified.


Management Analysis Update


Performance Analysis Update